EUCTR2012-002633-11-IT进行中（未招募）1 期
An open label, randomised, adaptive, multicenter, pharmacokinetic/pharmacodynamic, phase Ib, study of oseltamivir (Tamiflu®) in the treatment of influenza in immunocompromised children, between 0-18 years of age, with confirmed influenza infection.
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Male or female immunocompromised patients below or equal to 18 years of age with confirmed influenza (flu) infection.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 21
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients with hepatic decompensation, renal impairment or recent treatment with anti-viral medication.
研究者
相似试验
进行中（未招募）
1 期
A study in children and young adults with weak immunity and influenza (flu) infection to understand how the study drug (Tamiflu) improves the recovery from influenza (flu).EUCTR2012-002633-11-ESF. Hoffmann-La Roche Ltd.21
进行中（未招募）
不适用
Bioequivalence study of Azathioprine to measure the pharmacokinetic profiles, safety and tolerability of Test product when compared to the reference product.CTRI/2014/11/005175Alkem Laboratories Ltd40
进行中（未招募）
不适用
A bio-equivalence study to characterize the rate and extent of absorption of Melphalan after oraladministration and to assess the bioequivalence of the sponsorâ??s test productMelphalan Tablets 2 mg relative to that of the reference product ALKERAN®(melphalan) Tablets 2 mg in adult patientsCTRI/2013/12/004205Alvogen Pine Brook Inc60
已完成
不适用
A multicenter trial to characterize the rate and extent of Methotrexate absorption after oral administration and to assess the bioequivalence of the Methotrexate Tablets, USP 2.5mgCTRI/2018/10/015921otus Pharmaceutical Co Ltd50
已完成
不适用
Bioequivalence study of Quetiapine Fumarate 300 mg tablets in adult schizophrenia patients, who was already receiving Quetiapine in a stable regimeCTRI/2019/08/020536Prinston Pharmaceutical Inc